Induction of erythropoietin increases the cell proliferation rate in a hypoxia-inducible factor-1-dependent and -independent manner in renal cell carcinoma cell lines

Erythropoietin (Epo) is a potent inducer of erythropoiesis that is mainly produced in the kidney. Epo is expressed not only in the normal kidney, but also in renal cell carcinomas (RCCs). The aim of the present study was to gain insights into the roles of Epo and its receptor (EpoR) in RCC cells. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: FUJISUE, YUTAKA, NAKAGAWA, TAKATOSHI, TAKAHARA, KIYOSHI, INAMOTO, TERUO, KIYAMA, SATOSHI, AZUMA, HARUHITO, ASAHI, MICHIO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701060/
https://www.ncbi.nlm.nih.gov/pubmed/23833638
http://dx.doi.org/10.3892/ol.2013.1283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701060/
https://www.ncbi.nlm.nih.gov/pubmed/23833638
http://dx.doi.org/10.3892/ol.2013.1283

Ejemplares similares